A Study to Evaluate Safety and Tolerability of a Therapeutic Vaccine, ASP0113, in Subjects Undergoing Allogeneic Hematopoietic Cell Transplant
Clinical trial NCT01903928 · COMPLETED
Trial details
- NCT number
- NCT01903928
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-20
- Primary completion
- 2015-01-19
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.